HRP20150944T1 - Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju - Google Patents

Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju Download PDF

Info

Publication number
HRP20150944T1
HRP20150944T1 HRP20150944TT HRP20150944T HRP20150944T1 HR P20150944 T1 HRP20150944 T1 HR P20150944T1 HR P20150944T T HRP20150944T T HR P20150944TT HR P20150944 T HRP20150944 T HR P20150944T HR P20150944 T1 HRP20150944 T1 HR P20150944T1
Authority
HR
Croatia
Prior art keywords
oxo
hydroxy
ligands
metal ions
acid
Prior art date
Application number
HRP20150944TT
Other languages
English (en)
Croatian (hr)
Inventor
Jonathan Joseph Powell
Sylvaine Francoise Aline Bruggraber
Nuno Jorge Rodrigues Faria
Dora Isabel Amaral Pereira
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0702270.0A external-priority patent/GB0702270D0/en
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of HRP20150944T1 publication Critical patent/HRP20150944T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/76—Metal complexes of amino carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00—Compounds containing elements of Groups 6 or 16 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G99/00—Subject matter not provided for in other groups of this subclass

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
HRP20150944TT 2007-02-06 2008-02-06 Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju HRP20150944T1 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US88838607P 2007-02-06 2007-02-06
GBGB0702270.0A GB0702270D0 (en) 2007-02-06 2007-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
EP08709331.6A EP2125847B1 (en) 2007-02-06 2008-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
PCT/GB2008/000408 WO2008096130A1 (en) 2007-02-06 2008-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation

Publications (1)

Publication Number Publication Date
HRP20150944T1 true HRP20150944T1 (hr) 2015-10-09

Family

ID=39204358

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20150944TT HRP20150944T1 (hr) 2007-02-06 2008-02-06 Materijali poli-okso-hidroksi-metalnih iona modificirani ligandima, njihove uporabe i postupci za njihovu proizvodnju

Country Status (15)

Country Link
US (1) US8058462B2 (enExample)
EP (1) EP2125847B1 (enExample)
JP (1) JP5756598B2 (enExample)
KR (1) KR101514470B1 (enExample)
AU (1) AU2008212653B2 (enExample)
BR (1) BRPI0807212B1 (enExample)
CA (1) CA2676146C (enExample)
CY (1) CY1116590T1 (enExample)
EA (1) EA019635B1 (enExample)
GB (1) GB2451713B (enExample)
HR (1) HRP20150944T1 (enExample)
IL (1) IL199901A (enExample)
MX (1) MX2009008281A (enExample)
PL (1) PL2125847T3 (enExample)
WO (1) WO2008096130A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2125847B1 (en) 2007-02-06 2015-06-17 Medical Research Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
GB0814326D0 (en) * 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses
GB201101299D0 (en) 2011-01-25 2011-03-09 Medical Res Council Oxygen sensors and their uses
GB201507002D0 (en) * 2015-04-24 2015-06-10 Medical Res Council Copper Oxo-hydroxide nanoparticles and their uses as biocidal agents
GB201517893D0 (en) * 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
JP7033545B2 (ja) * 2016-03-31 2022-03-10 シールド ティーエックス （ユーケー） リミテッド 配位子修飾及び配位子コーティングされた水酸化第二鉄からマルトール第二鉄組成物を生成するための方法
CN109311837B (zh) 2016-03-31 2022-09-30 英国神盾Tx股份有限公司 用于由氢氧化亚铁产生麦芽酚铁组合物的方法
JP7510254B2 (ja) 2016-08-10 2024-07-03 ユナイテッド キングダム リサーチ アンド イノベーション ナノシリカ粒子を含む組成物および療法のためにｔリンパ球を活性化する方法におけるそれらの使用
SG11202001594TA (en) 2017-09-11 2020-03-30 Pharmacosmos Holding As Iron complex compounds for therapeutic use
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
WO2022061065A1 (en) * 2020-09-17 2022-03-24 Doyle Robert P Complexes of magnesium maltol (3-hydroxy-2-methyl-4h-pyran-4-one) for oral supplementation
AU2022323733A1 (en) 2021-08-03 2024-02-29 Pharmacosmos Holding A/S Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals
WO2026017897A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL264270A (enExample) *
US2575347A (en) * 1949-07-14 1951-11-20 Interchem Corp Metallo organic compounds
GB959282A (en) * 1959-08-19 1964-05-27 Hardman & Holden Ltd Improvements relating to organic aluminium compounds
US3076798A (en) 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
US3679377A (en) 1970-02-17 1972-07-25 Union Oil Co Iron complexes containing aquo,sulfate and hydroxyl ligands
US3821192A (en) 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
US4162986A (en) * 1977-06-20 1979-07-31 Mooney Chemicals, Inc. Oil-soluble high metal content transitional metal organic oxy, hydroxy, complexes
US4137359A (en) * 1977-10-31 1979-01-30 Mooney Chemicals, Inc. Elastomers with improved metal adhesion
DE4239442C2 (de) 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
US6177581B1 (en) 1999-10-12 2001-01-23 The Dow Chemical Company Mixed-metal chelates and process for the preparation thereof
US20030049284A1 (en) 2001-09-05 2003-03-13 Boccio Jose Ruben Method of increasing the solubility of alphahydrocarboxilic salts, and products obtained by the method
ES2357293T3 (es) 2001-10-08 2011-04-25 Purac Biochem N.V. Método de preparación de gluconato de calcio.
AU2003237552A1 (en) * 2002-01-24 2003-09-02 William Marsh Rice University Organic acid-feooh (ferroxane) particles and ferroxane-derived ceramics and ceramic membranes
US7994217B2 (en) 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US6706904B1 (en) 2002-12-04 2004-03-16 Albion International, Inc. Dimetalhydroxy malates
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US7964568B2 (en) 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
US7179939B2 (en) 2004-03-16 2007-02-20 Navinta Llc Sodium ferric gluconate complexes and method of manufacture thereof
WO2005094202A2 (en) 2004-03-16 2005-10-13 Navinta, Llc Iron sucrose complexes and method of manufacture thereof
BRPI0515847A (pt) 2004-10-08 2008-08-12 Unilever Nv uso de um complexo de ferro, composição alimentìcia, gênero alimentìcio fortificado com ferro, composição de bebida, bebida fortificada com ferro, suplemento alimentar e composição farmacêutica
DE202005014332U1 (de) 2005-09-09 2006-01-19 Institut für Oberflächenmodifizierung e.V. Metallorganisches Nanopulver
EP2125847B1 (en) 2007-02-06 2015-06-17 Medical Research Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
TWI592159B (zh) 2007-11-16 2017-07-21 威佛（國際）股份有限公司 藥學組成物
GB0814326D0 (en) 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses

Also Published As

Publication number Publication date
JP5756598B2 (ja) 2015-07-29
MX2009008281A (es) 2009-08-25
EP2125847B1 (en) 2015-06-17
IL199901A (en) 2014-11-30
GB0802214D0 (en) 2008-03-12
CA2676146A1 (en) 2008-08-14
CY1116590T1 (el) 2017-03-15
BRPI0807212A2 (pt) 2014-06-17
EP2125847A1 (en) 2009-12-02
US8058462B2 (en) 2011-11-15
BRPI0807212B1 (pt) 2022-01-11
PL2125847T3 (pl) 2015-12-31
GB2451713B (en) 2009-12-16
CA2676146C (en) 2016-08-09
JP2010520856A (ja) 2010-06-17
KR20090121281A (ko) 2009-11-25
US20080188555A1 (en) 2008-08-07
KR101514470B1 (ko) 2015-04-22
HK1138598A1 (en) 2010-08-27
AU2008212653A1 (en) 2008-08-14
WO2008096130A1 (en) 2008-08-14
IL199901A0 (en) 2010-04-15
GB2451713A (en) 2009-02-11
EA019635B1 (ru) 2014-05-30
AU2008212653B2 (en) 2012-05-24
EA200970718A1 (ru) 2010-02-26

Similar Documents

Publication Publication Date Title
Zhang et al. Photocatalytic degradation of tetracycline antibiotics using three-dimensional network structure perylene diimide supramolecular organic photocatalyst under visible-light irradiation
Tan et al. Activation of peroxymonosulfate by a novel EGCE@ Fe3O4 nanocomposite: Free radical reactions and implication for the degradation of sulfadiazine
JP2010520856A5 (enExample)
Zhang et al. Cobalt-doped boosted the peroxymonosulfate activation performance of LaFeO3 perovskite for atrazine degradation
Lateef et al. Synthesis and characterization of zeolite based nano–composite: An environment friendly slow release fertilizer
Li et al. Efficient degradation of trimethoprim by catalytic ozonation coupled with Mn/FeOx-functionalized ceramic membrane: Synergic catalytic effect and enhanced anti-fouling performance
Xu et al. Efficient removal of tetracycline using magnetic MnFe2O4/MoS2 nanocomposite activated peroxymonosulfate: Mechanistic insights and performance evaluation
Kefeni et al. Synthesis and characterization of magnetic nanoparticles and study their removal capacity of metals from acid mine drainage
Feng et al. Weak magnetic field accelerates chromate removal by zero-valent iron
CN104560046B (zh) 一种污染土壤钝化剂及其制备方法与应用
Chen et al. Catalytic thermal degradation of tetracycline based on iron-based MOFs and annealed derivative in dark condition
CN104556342B (zh) 六价铬污染土壤及地下水的修复药剂及制备方法
CN102897891A (zh) 一种复合型高锰酸钾缓释剂的制备方法
Niu et al. Catalytic performance of alkaline earth metals doped-Co3O4 for azo dye degradation by peroxymonosulfate activation
Fang et al. Impact of low-molecular weight organic acids on selenite immobilization by goethite: Understanding a competitive-synergistic coupling effect and speciation transformation
Shan et al. Magnetic Fe3O4-C@ MoS2 composites coordinated with peroxymonosulfate catalysis for enhanced tetracycline degradation
CN102725234A (zh) 微细铁混合物、微细铁混合物的使用方法、微细铁混合物的制造方法
Wang et al. Tea saponin co-ball milled commercial micro zero-valent iron for boosting Cr (VI) removal
JP2012075398A (ja) 鉄イオン供給材
Qin et al. Heterogeneous degradation of cefotaxime sodium with peroxymonosulfate activated by an effective and magnetically separable Ni0. 5Zn0. 5Fe2O4 catalyst
Yu et al. New insights into enhanced catalytic degradation of sulfamethoxazole using Fe-Zn@ biochar composite-activated periodate system: The combination of radical and non-radical pathways
CN115873601A (zh) 重金属钝化剂、土壤修复材料及镉砷复合污染物修复方法
Ma et al. Photo-assisted oxygen-rich vacancy copper oxide catalyst to activate peroxymonosulfate (PMS) for efficient degradation of fulvic acid
Li et al. Crucial role of Mn-doped FeNi layered double hydroxide in periodate activation toward enhancement of Fe (IV) and carbonate radical (· CO− 3) production
Liu et al. The simple preparation of robust mesoporous N/C co-doped Cu7. 2S4 for effectively removal of oxytetracycline based on activating peroxymonosulfate